Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis

被引：0
|
作者：
Chao Song
Tianwei Chen
Lan He
Ning Ma
Jian-ang Li
Ye-Fei Rong
Yuan Fang
Mengmeng Liu
Dong Xie
Wenhui Lou
机构：
[1] Fudan University,Department of Pancreatic Surgery, Zhongshan Hospital
[2] Chinese Academy of Sciences,Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences
[3] University of the Chinese Academy of Sciences,School of Life Science and Technology
[4] Shanghai Tech University,Department of Gastroenterology, Zhongshan Hospital
[5] Fudan University,undefined
来源：
Cellular Oncology | 2020年 / 43卷 / 1期
关键词：
D O I：
10.1007/s13402-019-00480-w
中图分类号：
学科分类号：
摘要：
The authors would like to correct the following panels in Figures
引用
收藏
页码：63 / 64
页数：1
相关论文
共 50 条
  • [21] GABRD promotes progression and predicts poor prognosis in colorectal cancer
    Niu, Gengming
    Deng, Li
    Zhang, Xiaotian
    Hu, Zhiqing
    Han, Shanliang
    Xu, Ke
    Hong, Runqi
    Meng, He
    Ke, Chongwei
    OPEN MEDICINE, 2020, 15 (01): : 1172 - 1183
  • [22] Correction: Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
    Jian-Yu Yang
    Shu-Heng Jiang
    De-Jun Liu
    Xiao-Mei Yang
    Yan-Miao Huo
    Jiao Li
    Rong Hua
    Zhi-Gang Zhang
    Yong-Wei Sun
    Scientific Reports, 5
  • [23] eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients
    Fan, A-hui
    Zhao, Xiaojuan
    Liu, Hao
    Li, Danxiu
    Guo, Tongtong
    Zhang, Jiehao
    Duan, Lili
    Cheng, Hao
    Nie, Yongzhan
    Fan, Daiming
    Zhao, Xiaodi
    Lu, Yuanyuan
    CANCER MEDICINE, 2023, 12 (01): : 513 - 524
  • [24] ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer
    Qiu, Xiao
    Feng, Jue-Rong
    Qiu, Jun
    Liu, Lan
    Xie, Yang
    Zhang, Yu-Peng
    Liu, Jing
    Zhao, Qiu
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 104 : 172 - 180
  • [25] WDR1 predicts poor prognosis and promotes cancer progression in hepatocellular carcinoma
    Zheng, Linhui
    Hu, Fang
    Li, Jiaxi
    Wang, Zhiwen
    Deng, Li
    Xiao, Benping
    Li, Jianfeng
    Lei, Xiong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5682 - 5693
  • [26] Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer
    Song, Jiandong
    Yang, Pengxia
    Lu, Jianjun
    CANCER BIOMARKERS, 2020, 27 (01) : 51 - 61
  • [27] Activator Protein-2β Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer
    Li, Zhenglin
    Xu, Xiangdong
    Luo, Meihua
    Hao, Jiaojiao
    Zhao, Shilei
    Yu, Wendan
    Xiao, Xiangsheng
    Wu, Jiali
    Zheng, Fufu
    Chen, Miao
    Li, Yizhuo
    Qin, Ge
    Liao, Yina
    Zhao, Xinrui
    Yu, Xinfa
    Guo, Wei
    Zou, Lijuan
    Deng, Wuguo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (05) : 1925 - 1935
  • [28] High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer
    Caiting Yang
    Peike Peng
    Lili Li
    Miaomiao Shao
    Junjie Zhao
    Lan Wang
    Fangfang Duan
    Shushu Song
    Hao Wu
    Jie Zhang
    Ran Zhao
    Dongwei Jia
    Mingming Zhang
    Weicheng Wu
    Can Li
    Yefei Rong
    Lei Zhang
    Yuanyuan Ruan
    Jianxin Gu
    Scientific Reports, 6
  • [29] High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer
    Yang, Caiting
    Peng, Peike
    Li, Lili
    Shao, Miaomiao
    Zhao, Junjie
    Wang, Lan
    Duan, Fangfang
    Song, Shushu
    Wu, Hao
    Zhang, Jie
    Zhao, Ran
    Jia, Dongwei
    Zhang, Mingming
    Wu, Weicheng
    Li, Can
    Rong, Yefei
    Zhang, Lei
    Ruan, Yuanyuan
    Gu, Jianxin
    SCIENTIFIC REPORTS, 2016, 6
  • [30] PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer
    Shimomura, Masahiro
    Fukuda, Takeshi
    Awazu, Yuichiro
    Nanno, Shigenori
    Inoue, Yuta
    Matsubara, Hiroaki
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2021, 21 (02)
12345